Aspect Biosystems

Aspect Biosystems is a biotechnology company pioneering Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases. Its full-stack tissue therapeutic platform integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells and advanced biomaterials to create implantable tissues that can replace, repair or supplement biological functions.

“At Aspect Biosystems, we’re pioneering a new category of regenerative medicine to restore function in the body and transform the lives of patients with serious diseases. Support from InBC strengthens our mission and B.C.’s growing biotech ecosystem, helping ensure that life-changing health innovations can be developed and scaled right here at home.”

— Tamer Mohamed, Founder & CEO, Aspect Biosystems

Established
2013

Aligned investment theme
Elevating inclusive communities

Purpose
To transform how we treat the most elusive diseases

Year invested
2024